Thrivent Healthcare Portfolio
Thrivent Healthcare Portfolio reported 45 holdings worth US$237M as of Jun 30, 2026 (Form N-PORT)
As of Jun 30, 2026 · Filed Aug 26, 2026
Thrivent Healthcare Portfolio reported 45 holdings worth US$237M as of Jun 30, 2026. Largest: Eli Lilly And Company, Johnson & Johnson and Abbvie Inc. Filed Aug 26, 2026 (Form N-PORT).
- Holdings
- 45
- Value as reported
- US$237M
The filing in full
| Company | Shares | Value as reported | % of portfolio |
|---|
| Eli Lilly And Company | 31,178 | US$37.4M | 15.8% |
| Johnson & Johnson | 84,431 | US$21.4M | 9.0% |
| Abbvie Inc. | 64,475 | US$16.2M | 6.8% |
| Unitedhealth Group Incorporated | 38,374 | US$15.9M | 6.7% |
| Merck & Company, Inc. | 77,482 | US$9.96M | 4.2% |
| Stryker Corporation | 28,542 | US$8.99M | 3.8% |
| Danaher Corporation | 40,038 | US$7.63M | 3.2% |
| Amgen Inc. | 19,089 | US$6.91M | 2.9% |
| Labcorp Holdings Inc. | 21,785 | US$6.1M | 2.6% |
| Cencora, Inc. | 20,389 | US$5.77M | 2.4% |
| Idexx Laboratories, Inc. | 10,675 | US$5.62M | 2.4% |
| Gilead Sciences, Inc. | 43,773 | US$5.53M | 2.3% |
| Abbott Laboratories | 59,436 | US$5.39M | 2.3% |
| Bristol-myers Squibb Company | 85,661 | US$4.94M | 2.1% |
| Medtronic Plc. | 60,889 | US$4.76M | 2.0% |
| Pfizer, Inc. | 185K | US$4.45M | 1.9% |
| Elevance Health, Inc. | 10,968 | US$4.24M | 1.8% |
| Mettler-toledo International, Inc. | 3,258 | US$4.16M | 1.8% |
| Intuitive Surgical, Inc. | 9,869 | US$3.92M | 1.7% |
| Thermo Fisher Scientific Inc | 7,772 | US$3.9M | 1.6% |
| Vertex Pharmaceuticals Incorporated | 7,391 | US$3.67M | 1.5% |
| Elanco Animal Health Incorporated | 141K | US$3.47M | 1.5% |
| Cvs Health Corporation | 33,071 | US$3.42M | 1.4% |
| Boston Scientific Corporation | 69,603 | US$2.97M | 1.3% |
| Iqvia Holdings, Inc. | 15,279 | US$2.95M | 1.2% |
| Encompass Health Corporation | 28,137 | US$2.84M | 1.2% |
| Tenet Healthcare Corporation | 15,001 | US$2.81M | 1.2% |
| Illumina, Inc. | 15,913 | US$2.8M | 1.2% |
| Regeneron Pharmaceuticals, Inc. | 4,408 | US$2.75M | 1.2% |
| Royalty Pharma Plc | 46,836 | US$2.63M | 1.1% |
| Dexcom, Inc. | 37,586 | US$2.53M | 1.1% |
| Argenx Se | 2,048 | US$1.9M | 0.80% |
| Ge Healthcare Technologies Inc. | 29,402 | US$1.88M | 0.79% |
| Mckesson Corporation | 2,430 | US$1.84M | 0.77% |
| Brightspring Health Services, Inc. | 25,970 | US$1.81M | 0.76% |
| United Therapeutics Corporation | 3,269 | US$1.77M | 0.75% |
| Biomarin Pharmaceutical Inc. | 30,349 | US$1.74M | 0.73% |
| Concentra Group Holdings Parent, Inc. | 57,658 | US$1.72M | 0.72% |
| The Cigna Group | 5,912 | US$1.63M | 0.69% |
| Humana Inc. | 4,087 | US$1.62M | 0.68% |
| Edwards Lifesciences Corporation | 16,337 | US$1.48M | 0.62% |
| Exelixis, Inc. | 25,643 | US$1.4M | 0.59% |
| Steris Plc (ireland) | 0 | US$0 | 0.00% |
| Bio-techne Corp | 0 | US$0 | 0.00% |
| Zoetis Inc. | 0 | US$0 | 0.00% |
Source
View original at SEC
Related